Diabetic Retinopathy Market (2025 - 2030) Size, Share & Trends Analysis Report By Type (Proliferative Diabetic Retinopathy), By Management (Anti-VEGF, Intraocular Steroid Injection, Laser Surgery, Vitrectomy), By Region And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Type
                        1.2.2. Management
                        1.2.3. Regional Scope
                        1.2.4. Estimates and Forecasts Timeline
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased Database
                        1.4.2. GVR’s Internal Database
                        1.4.3. Secondary Sources
                        1.4.4. Primary Research
                        1.4.5. Details of Primary Research
                    1.5. Information or Data Analysis
                        1.5.1. Data Analysis Models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Type Outlook
                        2.2.2. Management Outlook
                        2.2.3. Regional Outlook
                    2.3. Competitive Insights
Chapter 3. Diabetic Retinopathy Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent Market Outlook
                        3.1.2. Related/Ancillary Market Outlook
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                        3.2.2. Market Restraint Analysis
                    3.3. Diabetic Retinopathy Market Analysis tools
                        3.3.1. Industry Analysis - Porter’s
                            3.3.1.1. Supplier Power
                            3.3.1.2. Buyer Power
                            3.3.1.3. Substitution Threat
                            3.3.1.4. Threat of New Entrant
                            3.3.1.5. Competitive Rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political Landscape
                            3.3.2.2. Technological Landscape
                            3.3.2.3. Economic Landscape
Chapter 4. Diabetic Retinopathy Market: Type Estimates & Trend Analysis
                    4.1. Type Segment Dashboard
                    4.2. Diabetic Retinopathy Market: Type Movement Analysis
                    4.3. Global Diabetic Retinopathy Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
                    4.4. Proliferative Diabetic Retinopathy
                        4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
                    4.5. Non-Proliferative Diabetic Retinopathy
                        4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 5. Diabetic Retinopathy Market: Management Estimates & Trend Analysis
                    5.1. Management Segment Dashboard
                    5.2. Diabetic Retinopathy Market: Management Movement Analysis
                    5.3. Global Diabetic Retinopathy Market Size & Trend Analysis, by Management, 2018 to 2030 (USD Million)
                    5.4. Anti-VEGF
                        5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
                    5.5. Intraocular Steroid Injection
                        5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
                    5.6. Laser Surgery
                        5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
                    5.7. Vitrectomy
                        5.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 6. Diabetic Retinopathy Market: Regional Estimates & Trend Analysis
                    6.1. Regional Market Dashboard
                    6.2. Regional Market Share Analysis, 2024 & 2030
                    6.3. Continuous Bioprocessing Market By Region: Key Takeaways
                    6.4. North America
                        6.4.1. U.S.
                            6.4.1.1. Key Country Dynamics
                            6.4.1.2. Regulatory Framework/ Reimbursement Structure
                            6.4.1.3. Competitive Scenario
                            6.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
                        6.4.2. Canada
                            6.4.2.1. Key Country Dynamics
                            6.4.2.2. Regulatory Framework/ Reimbursement Structure
                            6.4.2.3. Competitive Scenario
                            6.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
                        6.4.3. Mexico
                            6.4.3.1. Key Country Dynamics
                            6.4.3.2. Regulatory Framework/ Reimbursement Structure
                            6.4.3.3. Competitive Scenario
                            6.4.3.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
                    6.5. Europe
                        6.5.1. UK
                            6.5.1.1. Key Country Dynamics
                            6.5.1.2. Regulatory Framework/ Reimbursement Structure
                            6.5.1.3. Competitive Scenario
                            6.5.1.4. UK Market Estimates and Forecasts 2018 to 2030 (USD Million)
                        6.5.2. Germany
                            6.5.2.1. Key Country Dynamics
                            6.5.2.2. Regulatory Framework/ Reimbursement Structure
                            6.5.2.3. Competitive Scenario
                            6.5.2.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
                        6.5.3. France
                            6.5.3.1. Key Country Dynamics
                            6.5.3.2. Regulatory Framework/ Reimbursement Structure
                            6.5.3.3. Competitive Scenario
                            6.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
                        6.5.4. Italy
                            6.5.4.1. Key Country Dynamics
                            6.5.4.2. Regulatory Framework/ Reimbursement Structure
                            6.5.4.3. Competitive Scenario
                            6.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
                        6.5.5. Spain
                            6.5.5.1. Key Country Dynamics
                            6.5.5.2. Regulatory Framework/ Reimbursement Structure
                            6.5.5.3. Competitive Scenario
                            6.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
                        6.5.6. Denmark
                            6.5.6.1. Key Country Dynamics
                            6.5.6.2. Regulatory Framework/ Reimbursement Structure
                            6.5.6.3. Competitive Scenario
                            6.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
                        6.5.7. Sweden
                            6.5.7.1. Key Country Dynamics
                            6.5.7.2. Regulatory Framework/ Reimbursement Structure
                            6.5.7.3. Competitive Scenario
                            6.5.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
                        6.5.8. Norway
                            6.5.8.1. Key Country Dynamics
                            6.5.8.2. Regulatory Framework/ Reimbursement Structure
                            6.5.8.3. Competitive Scenario
                            6.5.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
                    6.6. Asia Pacific
                        6.6.1. Japan
                            6.6.1.1. Key Country Dynamics
                            6.6.1.2. Regulatory Framework/ Reimbursement Structure
                            6.6.1.3. Competitive Scenario
                            6.6.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
                        6.6.2. China
                            6.6.2.1. Key Country Dynamics
                            6.6.2.2. Regulatory Framework/ Reimbursement Structure
                            6.6.2.3. Competitive Scenario
                            6.6.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
                        6.6.3. India
                            6.6.3.1. Key Country Dynamics
                            6.6.3.2. Regulatory Framework/ Reimbursement Structure
                            6.6.3.3. Competitive Scenario
                            6.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
                        6.6.4. South Korea
                            6.6.4.1. Key Country Dynamics
                            6.6.4.2. Regulatory Framework/ Reimbursement Structure
                            6.6.4.3. Competitive Scenario
                            6.6.4.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
                        6.6.5. Thailand
                            6.6.5.1. Key Country Dynamics
                            6.6.5.2. Regulatory Framework/ Reimbursement Structure
                            6.6.5.3. Competitive Scenario
                            6.6.5.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
                        6.6.6. Australia
                            6.6.6.1. Key Country Dynamics
                            6.6.6.2. Regulatory Framework/ Reimbursement Structure
                            6.6.6.3. Competitive Scenario
                            6.6.6.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
                    6.7. Latin America
                        6.7.1. Brazil
                            6.7.1.1. Key Country Dynamics
                            6.7.1.2. Regulatory Framework/ Reimbursement Structure
                            6.7.1.3. Competitive Scenario
                            6.7.1.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
                        6.7.2. Argentina
                            6.7.2.1. Key Country Dynamics
                            6.7.2.2. Regulatory Framework/ Reimbursement Structure
                            6.7.2.3. Competitive Scenario
                            6.7.2.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
                    6.8. MEA
                        6.8.1. South Africa
                            6.8.1.1. Key Country Dynamics
                            6.8.1.2. Regulatory Framework/ Reimbursement Structure
                            6.8.1.3. Competitive Scenario
                            6.8.1.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
                        6.8.2. Saudi Arabia
                            6.8.2.1. Key Country Dynamics
                            6.8.2.2. Regulatory Framework/ Reimbursement Structure
                            6.8.2.3. Competitive Scenario
                            6.8.2.4. Saudi Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
                        6.8.3. UAE
                            6.8.3.1. Key Country Dynamics
                            6.8.3.2. Regulatory Framework/ Reimbursement Structure
                            6.8.3.3. Competitive Scenario
                            6.8.3.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
                        6.8.4. Kuwait
                            6.8.4.1. Key Country Dynamics
                            6.8.4.2. Regulatory Framework/ Reimbursement Structure
                            6.8.4.3. Competitive Scenario
                            6.8.4.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
                    7.1. Recent Developments & Impact Analysis, By Key Market Participants
                    7.2. Company/Competition Categorization
                    7.3. Vendor Landscape
                        7.3.1. Key Company Heat Map Analysis, 2024
                    7.4. Company Profiles
                        7.4.1. Bayer AG
                            7.4.1.1. Company Overview
                            7.4.1.2. Financial Performance
                            7.4.1.3. Product Benchmarking
                            7.4.1.4. Strategic Initiatives
                        7.4.2. AbbVie Inc.
                            7.4.2.1. Company Overview
                            7.4.2.2. Financial Performance
                            7.4.2.3. Product Benchmarking
                            7.4.2.4. Strategic Initiatives
                        7.4.3. Novartis AG
                            7.4.3.1. Company Overview
                            7.4.3.2. Financial Performance
                            7.4.3.3. Product Benchmarking
                            7.4.3.4. Strategic Initiatives
                        7.4.4. Oxurion NV.
                            7.4.4.1. Company Overview
                            7.4.4.2. Financial Performance
                            7.4.4.3. Product Benchmarking
                            7.4.4.4. Strategic Initiatives
                        7.4.5. Sirnaomics, Inc.
                            7.4.5.1. Company Overview
                            7.4.5.2. Financial Performance
                            7.4.5.3. Product Benchmarking
                            7.4.5.4. Strategic Initiatives
                        7.4.6. Alimera Sciences
                            7.4.6.1. Company Overview
                            7.4.6.2. Financial Performance
                            7.4.6.3. Product Benchmarking
                            7.4.6.4. Strategic Initiatives
                        7.4.7. Ampio Pharmaceuticals Inc.
                            7.4.7.1. Company Overview
                            7.4.7.2. Financial Performance
                            7.4.7.3. Product Benchmarking
                            7.4.7.4. Strategic Initiatives
                        7.4.8. BCN Peptides
                            7.4.8.1. Company Overview
                            7.4.8.2. Financial Performance
                            7.4.8.3. Product Benchmarking
                            7.4.8.4. Strategic Initiatives
                        7.4.9. Kowa Company, Ltd.
                            7.4.9.1. Company Overview
                            7.4.9.2. Financial Performance
                            7.4.9.3. Product Benchmarking
                            7.4.9.4. Strategic Initiatives
                        7.4.10. Genentech, Inc.
                            7.4.10.1. Company Overview
                            7.4.10.2. Financial Performance
                            7.4.10.3. Product Benchmarking
                            7.4.10.4. Strategic Initiatives

List of Tables

Table 1 List of abbreviations
Table 2 North America diabetic retinopathy market, by country, 2018 - 2030 (USD Million)
Table 3 North America diabetic retinopathy market, by type, 2018 - 2030 (USD Million)
Table 4 North America diabetic retinopathy market, by management, 2018 - 2030 (USD Million)
Table 5 U.S. diabetic retinopathy market, by type, 2018 - 2030 (USD Million)
Table 6 U.S. diabetic retinopathy market, by management, 2018 - 2030 (USD Million)
Table 7 Canada diabetic retinopathy market, by type, 2018 - 2030 (USD Million)
Table 8 Canada diabetic retinopathy market, by management, 2018 - 2030 (USD Million)
Table 9 Mexico diabetic retinopathy market, by type, 2018 - 2030 (USD Million)
Table 10 Mexico diabetic retinopathy market, by management, 2018 - 2030 (USD Million)
Table 11 Europe diabetic retinopathy market, by country, 2018 - 2030 (USD Million)
Table 12 Europe diabetic retinopathy market, by type, 2018 - 2030 (USD Million)
Table 13 Europe diabetic retinopathy market, by management, 2018 - 2030 (USD Million)
Table 14 UK diabetic retinopathy market, by type, 2018 - 2030 (USD Million)
Table 15 UK diabetic retinopathy market, by management, 2018 - 2030 (USD Million)
Table 16 Germany diabetic retinopathy market, by type, 2018 - 2030 (USD Million)
Table 17 Germany diabetic retinopathy market, by management, 2018 - 2030 (USD Million)
Table 18 France diabetic retinopathy market, by type, 2018 - 2030 (USD Million)
Table 19 France diabetic retinopathy market, by management, 2018 - 2030 (USD Million)
Table 20 Italy diabetic retinopathy market, by type, 2018 - 2030 (USD Million)
Table 21 Italy diabetic retinopathy market, by management, 2018 - 2030 (USD Million)
Table 22 Spain diabetic retinopathy market, by type, 2018 - 2030 (USD Million)
Table 23 Spain diabetic retinopathy market, by management, 2018 - 2030 (USD Million)
Table 24 Denmark diabetic retinopathy market, by type, 2018 - 2030 (USD Million)
Table 25 Denmark diabetic retinopathy market, by management, 2018 - 2030 (USD Million)
Table 26 Sweden diabetic retinopathy market, by type, 2018 - 2030 (USD Million)
Table 27 Sweden diabetic retinopathy market, by management, 2018 - 2030 (USD Million)
Table 28 Norway diabetic retinopathy market, by type, 2018 - 2030 (USD Million)
Table 29 Norway diabetic retinopathy market, by management, 2018 - 2030 (USD Million)
Table 30 Asia Pacific diabetic retinopathy market, by country, 2018 - 2030 (USD Million)
Table 31 Asia Pacific diabetic retinopathy market, by type, 2018 - 2030 (USD Million)
Table 32 Asia Pacific diabetic retinopathy market, by management, 2018 - 2030 (USD Million)
Table 33 Japan diabetic retinopathy market, by type, 2018 - 2030 (USD Million)
Table 34 Japan diabetic retinopathy market, by management, 2018 - 2030 (USD Million)
Table 35 China diabetic retinopathy market, by type, 2018 - 2030 (USD Million)
Table 36 China diabetic retinopathy market, by management, 2018 - 2030 (USD Million)
Table 37 India diabetic retinopathy market, by type, 2018 - 2030 (USD Million)
Table 38 India diabetic retinopathy market, by management, 2018 - 2030 (USD Million)
Table 39 South Korea diabetic retinopathy market, by type, 2018 - 2030 (USD Million)
Table 40 South Korea diabetic retinopathy market, by management, 2018 - 2030 (USD Million)
Table 41 Thailand diabetic retinopathy market, by type, 2018 - 2030 (USD Million)
Table 42 Thailand diabetic retinopathy market, by management, 2018 - 2030 (USD Million)
Table 43 Australia diabetic retinopathy market, by type, 2018 - 2030 (USD Million)
Table 44 Australia diabetic retinopathy market, by management, 2018 - 2030 (USD Million)
Table 45 Latin America diabetic retinopathy market, by country, 2018 - 2030 (USD Million)
Table 46 Latin America diabetic retinopathy market, by type, 2018 - 2030 (USD Million)
Table 47 Latin America surgical ablation market, by management, 2018 - 2030 (USD Million)
Table 48 Brazil diabetic retinopathy market, by type, 2018 - 2030 (USD Million)
Table 49 Brazil diabetic retinopathy market, by management, 2018 - 2030 (USD Million)
Table 50 Argentina diabetic retinopathy market, by type, 2018 - 2030 (USD Million)
Table 51 Argentina diabetic retinopathy market, by management, 2018 - 2030 (USD Million)
Table 52 MEA diabetic retinopathy market, by country, 2018 - 2030 (USD Million)
Table 53 MEA diabetic retinopathy market, by type, 2018 - 2030 (USD Million)
Table 54 MEA diabetic retinopathy market, by management, 2018 - 2030 (USD Million)
Table 55 South Africa diabetic retinopathy market, by type, 2018 - 2030 (USD Million)
Table 56 South Africa diabetic retinopathy market, by management, 2018 - 2030 (USD Million)
Table 57 Saudi Arabia diabetic retinopathy market, by type, 2018 - 2030 (USD Million)
Table 58 Saudi Arabia diabetic retinopathy market, by management, 2018 - 2030 (USD Million)
Table 59 UAE diabetic retinopathy market, by type, 2018 - 2030 (USD Million)
Table 60 UAE diabetic retinopathy market, by management, 2018 - 2030 (USD Million)
Table 61 Kuwait diabetic retinopathy market, by type, 2018 - 2030 (USD Million)
Table 62 Kuwait diabetic retinopathy market, by management, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Diabetic retinopathy market: market outlook
Fig. 10 Diabetic retinopathy competitive insights
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Industry value chain analysis
Fig. 15 Diabetic retinopathy market driver impact
Fig. 16 Diabetic retinopathy market restraint impact
Fig. 17 Diabetic retinopathy market strategic initiatives analysis
Fig. 18 Diabetic retinopathy market: Type movement analysis
Fig. 19 Diabetic retinopathy market: Type outlook and key takeaways
Fig. 20 Proliferative diabetic retinopathy market estimates and forecast, 2018 - 2030
Fig. 21 Non-proliferative diabetic retinopathy estimates and forecast, 2018 - 2030
Fig. 22 Diabetic retinopathy market: Management movement analysis
Fig. 23 Diabetic retinopathy market: Management outlook and key takeaways
Fig. 24 Anti-VEGF market estimates and forecasts, 2018 - 2030
Fig. 25 Intraocular steroid injection market estimates and forecasts,2018 - 2030
Fig. 26 Laser surgery market estimates and forecasts, 2018 - 2030
Fig. 27 Vitrectomy market estimates and forecasts, 2018 - 2030
Fig. 28 Global diabetic retinopathy market: regional movement analysis
Fig. 29 Global diabetic retinopathy market: regional outlook and key takeaways
Fig. 30 North America market estimates and forecasts, 2018 - 2030
Fig. 31 U.S. market estimates and forecasts, 2018 - 2030
Fig. 32 Canada market estimates and forecasts, 2018 - 2030
Fig. 33 Mexico market estimates and forecasts, 2018 - 2030
Fig. 34 Europe market estimates and forecasts, 2018 - 2030
Fig. 35 UK market estimates and forecasts, 2018 - 2030
Fig. 36 Germany market estimates and forecasts, 2018 - 2030
Fig. 37 France market estimates and forecasts, 2018 - 2030
Fig. 38 Italy market estimates and forecasts, 2018 - 2030
Fig. 39 Spain market estimates and forecasts, 2018 - 2030
Fig. 40 Denmark market estimates and forecasts, 2018 - 2030
Fig. 41 Sweden market estimates and forecasts, 2018 - 2030
Fig. 42 Norway market estimates and forecasts, 2018 - 2030
Fig. 43 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 44 Japan market estimates and forecasts, 2018 - 2030
Fig. 45 China market estimates and forecasts, 2018 - 2030
Fig. 46 India market estimates and forecasts, 2018 - 2030
Fig. 47 South Korea market estimates and forecasts, 2018 - 2030
Fig. 48 Thailand market estimates and forecasts, 2018 - 2030
Fig. 49 Australia market estimates and forecasts, 2018 - 2030
Fig. 50 Latin America market estimates and forecasts, 2018 - 2030
Fig. 51 Brazil market estimates and forecasts, 2018 - 2030
Fig. 52 Argentina market estimates and forecasts, 2018 - 2030
Fig. 53 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 54 South Africa market estimates and forecasts, 2018 - 2030
Fig. 55 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 56 UAE market estimates and forecasts, 2018 - 2030
Fig. 57 Kuwait market estimates and forecasts, 2018 - 2030